In our latest podcast episode of Securing the Digital Future, Freshfields partner Rachael Annear is joined by Michelle Ramsden from the US Department of Justice for an overview of the status of online safety regulation in the US. 

Listen to the latest episode of the Freshfields MedTech podcast as partner Vinita Kailasanath and Managing Director of Ivy Tree Advisors, Jonathan Olsen, discuss key MedTech hot topics coming out of this year’s J.P. Morgan Healthcare Conference.

Join partners Takeshi Nakao (Tokyo) and Vinita Kailasanath (Silicon Valley) for the latest episode of the Freshfields MedTech podcast. With a focus on Japan and the US, they discuss trends and innovations in MedTech, and potential risk and regulation that companies with MedTech products and services face.

In our first Essential Antitrust podcast of 2024, host Jenn Mellott is joined by Alastair Chapman, Ninette Dodoo and Mark Sansom to explore some of the themes highlighted in “Global antitrust in 2024: 10 key themes”, our recent report on the biggest trends in antitrust for the year ahead.

The Digital Markets, Competition and Consumers Bill will introduce the most significant reforms to UK competition and consumer laws since the CMA was established in 2014.

Olivia Wyld and Johanna Nerona speak at Legal Geek, a legal tech conference, about how we use legal project management and empathetic leadership to support the management of matters and to go from chaos to control.

In this episode of our MedTech podcast series, Freshfields Partners Vinita Kailasanath and Timothy Howard and Principal Associate Philipp Roos discuss what is top of mind for clients in terms of health data considerations, including with respect to AI usage, in both the US and EU.

In this episode of our MedTech podcast series, Freshfields Partner Vinita Kailasanath and Jhaymee Tynan, Principal, Healthcare Services at Korn Ferry, and author of Inclusive Sponsorship: A Bold Vision to Advance Women of Color in the Workplace, discuss MedTech trends they are tracking, inclusivity in MedTech, and approaches that MedTech companies can take to bridge health disparities.

In 2023 antitrust enforcement will continue to respond to calls for it to do more to address a range of global crises and social concerns. Authorities are being given enhanced powers and new tools, and are tackling novel kinds of cases, which is significantly increasing unpredictability.

In this episode of our MedTech podcast series, Freshfields Partner Vinita Kailasanath and Stacy Hostetler, Co-Leader of Egon Zehnder’s Medical Technology Practice discuss the convergence between tech and life sciences, diversity in the industry ecosystem and whether you should have a sponsor or a mentor.

In this episode of our MedTech podcast series, Freshfields partners Vinita Kailasanath and Theresa Ehlen sit down with Gloria Seibert – Founder and CEO of Temedica – to discuss the future of digital health innovations and to reflect on Gloria’s own experiences as a founder and entrepreneur in the MedTech industry.

Supported by increasing demand, partially fuelled by the impact of COVID-19, recent years have seen the life sciences sector develop into a critical growth area in Asia Pacific, which is home to approximately 60% of the world’s population. As a result, global investors are increasingly looking at opportunities in the region to capitalise on the demand. At the same time, Asian investors are increasingly expanding their footprint outside Asia Pacific.

In this episode of our MedTech podcast series, Freshfields Partner Vinita Kailasanath sits down with Marissa Fayer – CEO and Founder of HERhealthEQ – to discuss trends in the global women’s healthcare market, including the women’s health industry’s growth beyond fertility solutions, efforts to increase clinical trial diversity, health equity, and more.

In the first of a new podcast series exploring the fast-evolving world of MedTech, Freshfields Partner Vinita Kailasanath sits down with Matthew Holt – MedTech blogger, trend-spotter and self-confessed ‘healthcare curmudgeon’ – to talk about the future of machine learning in healthcare, telemedicine, digital therapeutics and much more.

Data issues are increasingly in the spotlight in the tech and life sciences sectors, requiring a holistic approach to antitrust and data protection considerations.

Licensing and collaboration agreements, integral to the life sciences and tech industries, are increasingly complex from an antitrust perspective.

In this podcast, Claire Harrop, Thomas Clark, Pamela Marcogliese and Kenneth Hui use their perspectives from a range of sectors and jurisdictions to discuss the key governance matters fintechs face today.

In this episode of our Tax Matters podcast Joshua Critchlow interviews Lorand Bartels, Katharina Kubik and Brin Rajathurai about the implications of these recent agreements and what trade law challenges may remain in relation to DSTs. The team also discuss tax developments on the horizon that will need to be monitored from a trade perspective and explore challenges around getting the OECD agreement implemented in the US.